Login
← Go Back
Novartis India
NOVARTIND · Retail > Trading · Chairman: C Snook · MD: Sanjay Murdeshwar · Listing date: Nov. 9, 2000 · Employees: 539 · Mumbai · http://www.novartis.in
Stock Price vs Company Growth
1d
3.9%
1w
7.2%
1m
10.5%
3m
34.3%
6m
33.1%
1y
42.2%
5y
14.1%
all
11.6%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,107 3.9%
787
1,121
Company Overview
Sales
348 Cr
Growth: 0.6%
Profit after Tax
97.2 Cr
Growth: -8.8%
Small Cap
2,733 Cr
P/E: 28.2x
Industry P/E: 24.9x
Fundamentals
Sales (Cr) ₹ 348
Growth 0.6%
EBITDA 28.0%
P/S 7.9x
Dividend 2.4%
P/E 28.2x
Book Value ₹ 345
PEG Ratio 43.3x
ROE 11.8%
P/B 3.0x
Shareholding Pattern
Institutions
Promoters
Novartis Ag
70.68 %
Others
Atul Limited
1.52 %
Iepf
0.47 %
Llp, Partnership Firm, Directors' Relative
0.14 %
Increase    Decrease    No change
Company Profile Detailed
As a science-based and patient-oriented healthcare company, it strives to be a global leader in growing areas of healthcare. Following a corporate transformation Novartis globally is focused on three divisions with global scale and innovation power - pharmaceuticals, eye care and generic medicines. This has strengthened the future growth prospects of the company.
Belongs to (8 Indices) view more
Investors (7)
abdul.ha...
iepf
total
Followers (1)
varsha96